Your browser doesn't support javascript.
COVID-19 and radiation oncology: the experience of a two-phase plan within a single institution in central Italy.
Caravatta, Luciana; Rosa, Consuelo; Di Sciascio, Maria Bernadette; Tavella Scaringi, Andrea; Di Pilla, Angelo; Ursini, Lucia Anna; Taraborrelli, Maria; Vinciguerra, Annamaria; Augurio, Antonietta; Di Tommaso, Monica; Trignani, Marianna; Nuzzo, Marianna; Falco, Maria Daniela; De Nicola, Andrea; Adorante, Nico; Patani, Fabiola; Centofanti, Giuseppe; Gasparini, Lucrezia; Fasciolo, David; Di Guglielmo, Fiorella Cristina; Bonfiglio, Cecilia; Borgia, Marzia; Caravaggio, Gabriella; Marcucci, Stefano; Turchi, Consalvo; Mancinelli, Domenico; Sartori, Stephanie; Schael, Thomas; Muraglia, Angelo; Caputi, Sergio; D'Amario, Claudio; Verì, Nicoletta; Genovesi, Domenico.
  • Caravatta L; Department of Radiation Oncology, "SS Annunziata" Hospital, "G. D'Annunzio" University, Via Dei Vestini, 66100, Chieti, Italy. lcaravatta@hotmail.com.
  • Rosa C; Department of Radiation Oncology, "SS Annunziata" Hospital, "G. D'Annunzio" University, Via Dei Vestini, 66100, Chieti, Italy.
  • Di Sciascio MB; Department of Neuroscience, Imaging and Clinical Sciences, "G. D'Annunzio" University, Chieti, Italy.
  • Tavella Scaringi A; Quality and Clinical Governance "SS Annunziata" Hospital, Chieti, Italy.
  • Di Pilla A; Quality and Clinical Governance "SS Annunziata" Hospital, Chieti, Italy.
  • Ursini LA; Department of Radiation Oncology, "SS Annunziata" Hospital, "G. D'Annunzio" University, Via Dei Vestini, 66100, Chieti, Italy.
  • Taraborrelli M; Department of Radiation Oncology, "SS Annunziata" Hospital, "G. D'Annunzio" University, Via Dei Vestini, 66100, Chieti, Italy.
  • Vinciguerra A; Department of Radiation Oncology, "SS Annunziata" Hospital, "G. D'Annunzio" University, Via Dei Vestini, 66100, Chieti, Italy.
  • Augurio A; Department of Radiation Oncology, "SS Annunziata" Hospital, "G. D'Annunzio" University, Via Dei Vestini, 66100, Chieti, Italy.
  • Di Tommaso M; Department of Radiation Oncology, "SS Annunziata" Hospital, "G. D'Annunzio" University, Via Dei Vestini, 66100, Chieti, Italy.
  • Trignani M; Department of Radiation Oncology, "SS Annunziata" Hospital, "G. D'Annunzio" University, Via Dei Vestini, 66100, Chieti, Italy.
  • Nuzzo M; Department of Radiation Oncology, "SS Annunziata" Hospital, "G. D'Annunzio" University, Via Dei Vestini, 66100, Chieti, Italy.
  • Falco MD; Department of Radiation Oncology, "SS Annunziata" Hospital, "G. D'Annunzio" University, Via Dei Vestini, 66100, Chieti, Italy.
  • De Nicola A; Department of Radiation Oncology, "SS Annunziata" Hospital, "G. D'Annunzio" University, Via Dei Vestini, 66100, Chieti, Italy.
  • Adorante N; Department of Radiation Oncology, "SS Annunziata" Hospital, "G. D'Annunzio" University, Via Dei Vestini, 66100, Chieti, Italy.
  • Patani F; Department of Radiation Oncology, "SS Annunziata" Hospital, "G. D'Annunzio" University, Via Dei Vestini, 66100, Chieti, Italy.
  • Centofanti G; Department of Radiation Oncology, "SS Annunziata" Hospital, "G. D'Annunzio" University, Via Dei Vestini, 66100, Chieti, Italy.
  • Gasparini L; Department of Radiation Oncology, "SS Annunziata" Hospital, "G. D'Annunzio" University, Via Dei Vestini, 66100, Chieti, Italy.
  • Fasciolo D; Department of Radiation Oncology, "SS Annunziata" Hospital, "G. D'Annunzio" University, Via Dei Vestini, 66100, Chieti, Italy.
  • Di Guglielmo FC; Department of Radiation Oncology, "SS Annunziata" Hospital, "G. D'Annunzio" University, Via Dei Vestini, 66100, Chieti, Italy.
  • Bonfiglio C; Department of Radiation Oncology, "SS Annunziata" Hospital, "G. D'Annunzio" University, Via Dei Vestini, 66100, Chieti, Italy.
  • Borgia M; Department of Radiation Oncology, "SS Annunziata" Hospital, "G. D'Annunzio" University, Via Dei Vestini, 66100, Chieti, Italy.
  • Caravaggio G; Department of Radiation Oncology, "SS Annunziata" Hospital, "G. D'Annunzio" University, Via Dei Vestini, 66100, Chieti, Italy.
  • Marcucci S; Department of Radiation Oncology, "SS Annunziata" Hospital, "G. D'Annunzio" University, Via Dei Vestini, 66100, Chieti, Italy.
  • Turchi C; Department of Radiation Oncology, "SS Annunziata" Hospital, "G. D'Annunzio" University, Via Dei Vestini, 66100, Chieti, Italy.
  • Mancinelli D; Department of Radiation Oncology, "SS Annunziata" Hospital, "G. D'Annunzio" University, Via Dei Vestini, 66100, Chieti, Italy.
  • Sartori S; Department of Radiation Oncology, "SS Annunziata" Hospital, "G. D'Annunzio" University, Via Dei Vestini, 66100, Chieti, Italy.
  • Schael T; Department of Radiation Oncology, "SS Annunziata" Hospital, "G. D'Annunzio" University, Via Dei Vestini, 66100, Chieti, Italy.
  • Muraglia A; Management "SS Annunziata" Hospital, Chieti, Italy.
  • Caputi S; Management "SS Annunziata" Hospital, Chieti, Italy.
  • D'Amario C; Rector "G. D'Annunzio" University, Chieti, Italy.
  • Verì N; Abruzzo Region Health Policy Department, L'Aquila, Italy.
  • Genovesi D; Abruzzo Region Health Policy Department, L'Aquila, Italy.
Radiat Oncol ; 15(1): 226, 2020 Sep 29.
Article in English | MEDLINE | ID: covidwho-800868
ABSTRACT

BACKGROUND:

COVID-19 in Italy has led to the need to reorganize hospital protocols with a significant risk of interruption to cancer treatment programs. In this report, we will focus on a management model covering the two phases of the COVID-19 emergency, namely lockdown-phase I and post-lockdown-phase II.

METHODS:

The following steps were taken in the two phases workload during visits and radiotherapy planning, use of dedicated routes, measures for triage areas, management of suspected and positive COVID-19 cases, personal protective equipment, hospital environments and intra-institutional meetings and tumor board management. Due to the guidelines set out by the Ministry of Health, oncological follow-up visits were interrupted during the lockdown-phase I; consequently, we set about contacting patients by telephone, with laboratory and instrumental exams being viewed via telematics. During the post-lockdown-phase II, the oncological follow-up clinic reopened, with two shifts operating daily.

RESULTS:

By comparing our radiotherapy activity from March 9 to May 4 2019 with the same period in 2020 during full phase I of the COVID-19 emergency, similar results were achieved. First radiotherapy visits, Simulation Computed Tomography and Linear Accelerator treatments amounted to 123, 137 and 151 in 2019 compared with 121, 135 and 170 in 2020 respectively. There were no cases of COVID-19 positivity recorded either in patients or in healthcare professionals, who were all negative to the swab tests performed.

CONCLUSION:

During both phases of the COVID-19 emergency, the planned model used in our own experience guaranteed both continuity in radiotherapy treatments whilst neither reducing workload nor interrupting treatment and, as such, it ensured the safety of cancer patients, hospital environments and staff.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Infection Control / Coronavirus Infections / Radiation Oncology / Pandemics / Neoplasms Type of study: Cohort study / Observational study / Prognostic study Topics: Long Covid Limits: Humans Country/Region as subject: Europa Language: English Journal: Radiat Oncol Journal subject: Neoplasms / Radiotherapy Year: 2020 Document Type: Article Affiliation country: S13014-020-01670-9

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Infection Control / Coronavirus Infections / Radiation Oncology / Pandemics / Neoplasms Type of study: Cohort study / Observational study / Prognostic study Topics: Long Covid Limits: Humans Country/Region as subject: Europa Language: English Journal: Radiat Oncol Journal subject: Neoplasms / Radiotherapy Year: 2020 Document Type: Article Affiliation country: S13014-020-01670-9